Schrodinger, Inc.
SDGRNasdaqCIK 1490978HealthcareFiscal year ends Dec 31
Reports and events: 95 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-0416:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001490978-23-000047 |
| 2023-04-2707:37 ET | DEF 14A | Proxy statement | 0001490978-23-000039 |
| 2023-04-1316:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001490978-23-000029 |
| 2023-02-2816:04 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001490978-23-000024 |
| 2023-02-2816:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001490978-23-000023 |
| 2022-11-0316:03 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001490978-22-000012 |
| 2022-11-0316:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001490978-22-000011 |
| 2022-08-1807:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001564590-22-029714 |
| 2022-08-0416:14 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001564590-22-028010 |
| 2022-08-0416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-028003 |
| 2022-06-1616:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-22-175530 |
| 2022-05-1907:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001564590-22-020696 |
| 2022-05-0416:12 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001564590-22-017856 |
| 2022-05-0416:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-017846 |
| 2022-04-2808:00 ET | DEF 14A | Proxy statementPeriod 2022-06-15 | 0001564590-22-016235 |
| 2022-03-0216:23 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-063008 |
| 2022-02-2416:17 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001564590-22-006713 |
| 2022-02-2416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-22-006692 |
| 2021-12-2107:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-21-363016 |
| 2021-11-1016:16 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056203 |
| 2021-11-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-056175 |
| 2021-08-1210:17 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043687 |
| 2021-08-1208:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950123-21-010437 |
| 2021-06-2107:30 ET | 8-K | 5.07 Shareholder vote results | 0001564590-21-033460 |
| 2021-05-1107:30 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-026289 |
| 2021-05-1107:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-026281 |
| 2021-04-2808:15 ET | DEF 14A | Proxy statementPeriod 2021-06-17 | 0001564590-21-021121 |
| 2021-04-0816:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001564590-21-018181 |
| 2021-03-2307:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-21-090368 |
| 2021-03-0407:30 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-010727 |
| 2021-03-0407:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-010719 |
| 2020-11-2306:37 ET | 8-K | 1.01 Entry into a material agreement | 0001193125-20-300273 |
| 2020-11-1207:34 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-053292 |
| 2020-11-1207:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-053268 |
| 2020-08-1016:15 ET | S-1 | Registration statement | 0001193125-20-214928 |
| 2020-08-1007:00 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-038584 |
| 2020-08-1006:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-20-038566 |
| 2020-06-1207:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-20-167157 |
| 2020-05-1316:31 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001564590-20-025087 |
| 2020-05-1307:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-20-141060 |
| 2020-05-0407:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-131704 |
| 2020-03-1616:37 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001564590-20-011182 |
| 2020-02-1016:44 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-20-029889 |
| 2020-01-2706:12 ET | S-1/A | Registration statement, amended | 0001193125-20-014624 |
| 2020-01-1017:13 ET | S-1 | Registration statement | 0001193125-20-005504 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:30 ET. Listed shows no prices and gives no investment advice.